title: [THE EFFECTIVENESS OF A 10-DAY DRUG THERAPY IN CHILDREN WITH CHRONIC GASTRODUODENAL PATHOLOGY ASSOCIATED WITH CAGA-POSITIVE STRAINS OF HELICOBACTER PYLORI].
abstract: The results of triple Helicobacter-therapy (omeprazole, amoxicillin, nifuratel) in the treatment of chronic gastroduodenal pathology in children depending on the duration of it's use. The effectiveness of drug therapy was evaluated in terms of eradication of Helicobacter pylori and dynamics of pain, dyspeptic syndrome and astenovegetative syndrome.
authors.forename: V M
authors.initials: VM
authors.lastname: Dudnyk
authors.forename: G M
authors.initials: GM
authors.lastname: Rudenko
mesh_terms: D000293:Adolescent; D000658:Amoxicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000942:Antigens, Bacterial / Q000235:genetics / Q000378:metabolism; D001426:Bacterial Proteins / Q000235:genetics / Q000378:metabolism; D002648:Child; D002908:Chronic Disease; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D004382:Duodenitis / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology / Q000503:physiopathology; D005756:Gastritis / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology / Q000503:physiopathology; D015870:Gene Expression; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology / Q000503:physiopathology; D016480:Helicobacter pylori / Q000187:drug effects* / Q000235:genetics / Q000254:growth & development / Q000472:pathogenicity; D006801:Humans; D009545:Nifuratel / Q000627:therapeutic use; D009853:Omeprazole / Q000627:therapeutic use; D010146:Pain / Q000150:complications / Q000382:microbiology / Q000503:physiopathology / Q000517:prevention & control*; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D000942:Antigens, Bacterial; D001426:Bacterial Proteins; C080866:cagA protein, Helicobacter pylori; D000658:Amoxicillin; D009853:Omeprazole; D009545:Nifuratel